PDB Short entry for 2NV7 HEADER TRANSCRIPTION 10-NOV-06 2NV7 TITLE CRYSTAL STRUCTURE OF ESTROGEN RECEPTOR BETA COMPLEXED WITH WAY-555 COMPND MOL_ID: 1; COMPND 2 MOLECULE: ESTROGEN RECEPTOR BETA; COMPND 3 CHAIN: A, B; COMPND 4 SYNONYM: ER-BETA; COMPND 5 ENGINEERED: YES; COMPND 6 MOL_ID: 2; COMPND 7 MOLECULE: NUCLEAR RECEPTOR COACTIVATOR 1; COMPND 8 CHAIN: C, D; COMPND 9 SYNONYM: NCOA-1, STEROID RECEPTOR COACTIVATOR 1, SRC-1, RIP160, COMPND 10 PROTEIN HIN-2, NY-REN-52 ANTIGEN; COMPND 11 EC: 2.3.1.48; COMPND 12 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: ESR2, ESTRB, NR3A2; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI BL21(DE3); SOURCE 7 EXPRESSION_SYSTEM_TAXID: 469008; SOURCE 8 EXPRESSION_SYSTEM_STRAIN: BL21DE3; SOURCE 9 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 10 EXPRESSION_SYSTEM_PLASMID: PET16B; SOURCE 11 MOL_ID: 2; SOURCE 12 SYNTHETIC: YES; SOURCE 13 OTHER_DETAILS: THIS SEQUENCE WAS DERIVED FROM STEROID RECEPTOR SOURCE 14 COACTIVATOR-1 KEYWDS ESTROGEN RECEPTOR, ESTROGEN RECEPTOR BETA, ER-BETA, ER, ESTROGEN, KEYWDS 2 NUCLEAR RECEPTOR, TRANSCRIPTION FACTOR, AGONIST, STRUCTURAL KEYWDS 3 GENOMICS, NPPSFA, NATIONAL PROJECT ON PROTEIN STRUCTURAL AND KEYWDS 4 FUNCTIONAL ANALYSES, RIKEN STRUCTURAL GENOMICS/PROTEOMICS KEYWDS 5 INITIATIVE, RSGI, TRANSCRIPTION EXPDTA X-RAY DIFFRACTION AUTHOR R.E.MEWSHAW,M.S.BOWEN,H.A.HARRIS,Z.B.XU,E.S.MANAS,S.T.COHN,RIKEN AUTHOR 2 STRUCTURAL GENOMICS/PROTEOMICS INITIATIVE (RSGI) REVDAT 4 03-APR-24 2NV7 1 REMARK REVDAT 3 27-DEC-23 2NV7 1 REMARK REVDAT 2 24-FEB-09 2NV7 1 VERSN REVDAT 1 21-AUG-07 2NV7 0 JRNL AUTH R.E.MEWSHAW,S.M.BOWEN,H.A.HARRIS,Z.B.XU,E.S.MANAS,S.T.COHN JRNL TITL ERBETA LIGANDS. PART 5: SYNTHESIS AND STRUCTURE-ACTIVITY JRNL TITL 2 RELATIONSHIPS OF A SERIES OF JRNL TITL 3 4'-HYDROXYPHENYL-ARYL-CARBALDEHYDE OXIME DERIVATIVES. JRNL REF BIOORG.MED.CHEM.LETT. V. 17 902 2007 JRNL REFN ISSN 0960-894X JRNL PMID 17188490 JRNL DOI 10.1016/J.BMCL.2006.11.066 REMARK 2 REMARK 2 RESOLUTION. 2.10 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : CNS 1.1 REMARK 3 AUTHORS : BRUNGER,ADAMS,CLORE,DELANO,GROS,GROSSE- REMARK 3 : KUNSTLEVE,JIANG,KUSZEWSKI,NILGES,PANNU, REMARK 3 : READ,RICE,SIMONSON,WARREN REMARK 3 REMARK 3 REFINEMENT TARGET : ENGH & HUBER REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.10 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 19.99 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 DATA CUTOFF HIGH (ABS(F)) : 2413103.700 REMARK 3 DATA CUTOFF LOW (ABS(F)) : 0.0000 REMARK 3 COMPLETENESS (WORKING+TEST) (%) : 98.2 REMARK 3 NUMBER OF REFLECTIONS : 27204 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING SET) : 0.211 REMARK 3 FREE R VALUE : 0.265 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 4.900 REMARK 3 FREE R VALUE TEST SET COUNT : 1327 REMARK 3 ESTIMATED ERROR OF FREE R VALUE : 0.007 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 6 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 2.10 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 2.23 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 91.80 REMARK 3 REFLECTIONS IN BIN (WORKING SET) : 3966 REMARK 3 BIN R VALUE (WORKING SET) : 0.2050 REMARK 3 BIN FREE R VALUE : 0.2620 REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : 4.80 REMARK 3 BIN FREE R VALUE TEST SET COUNT : 202 REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : 0.019 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 3731 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 40 REMARK 3 SOLVENT ATOMS : 246 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 14.90 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 25.60 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : -0.97000 REMARK 3 B22 (A**2) : 1.50000 REMARK 3 B33 (A**2) : -0.53000 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM LUZZATI PLOT (A) : 0.25 REMARK 3 ESD FROM SIGMAA (A) : 0.12 REMARK 3 LOW RESOLUTION CUTOFF (A) : 5.00 REMARK 3 REMARK 3 CROSS-VALIDATED ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM C-V LUZZATI PLOT (A) : 0.32 REMARK 3 ESD FROM C-V SIGMAA (A) : 0.19 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 BOND LENGTHS (A) : 0.010 REMARK 3 BOND ANGLES (DEGREES) : 1.300 REMARK 3 DIHEDRAL ANGLES (DEGREES) : 19.20 REMARK 3 IMPROPER ANGLES (DEGREES) : 0.930 REMARK 3 REMARK 3 ISOTROPIC THERMAL MODEL : RESTRAINED REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. RMS SIGMA REMARK 3 MAIN-CHAIN BOND (A**2) : 1.000 ; 1.500 REMARK 3 MAIN-CHAIN ANGLE (A**2) : 1.690 ; 2.000 REMARK 3 SIDE-CHAIN BOND (A**2) : 1.550 ; 2.000 REMARK 3 SIDE-CHAIN ANGLE (A**2) : 2.380 ; 2.500 REMARK 3 REMARK 3 BULK SOLVENT MODELING. REMARK 3 METHOD USED : FLAT MODEL REMARK 3 KSOL : 0.37 REMARK 3 BSOL : 45.35 REMARK 3 REMARK 3 NCS MODEL : NULL REMARK 3 REMARK 3 NCS RESTRAINTS. RMS SIGMA/WEIGHT REMARK 3 GROUP 1 POSITIONAL (A) : NULL ; NULL REMARK 3 GROUP 1 B-FACTOR (A**2) : NULL ; NULL REMARK 3 REMARK 3 PARAMETER FILE 1 : PROTEIN_REP.PARAM REMARK 3 PARAMETER FILE 2 : WATER_REP.PARAM REMARK 3 PARAMETER FILE 3 : ION.PARAM REMARK 3 PARAMETER FILE 4 : 555.PAR REMARK 3 PARAMETER FILE 5 : NULL REMARK 3 TOPOLOGY FILE 1 : PROTEIN.TOP REMARK 3 TOPOLOGY FILE 2 : WATER.TOP REMARK 3 TOPOLOGY FILE 3 : ION.TOP REMARK 3 TOPOLOGY FILE 4 : 555.TOP REMARK 3 TOPOLOGY FILE 5 : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 2NV7 COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 14-NOV-06. REMARK 100 THE DEPOSITION ID IS D_1000040341. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : NULL REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 8.0 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : NSLS REMARK 200 BEAMLINE : X26C REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : ADSC QUANTUM 4 REMARK 200 INTENSITY-INTEGRATION SOFTWARE : HKL-2000 REMARK 200 DATA SCALING SOFTWARE : HKL-2000 REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 27204 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.100 REMARK 200 RESOLUTION RANGE LOW (A) : 20.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : 1.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 96.5 REMARK 200 DATA REDUNDANCY : NULL REMARK 200 R MERGE (I) : 0.07500 REMARK 200 R SYM (I) : NULL REMARK 200 <I/SIGMA(I)> FOR THE DATA SET : NULL REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : NULL REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : NULL REMARK 200 COMPLETENESS FOR SHELL (%) : NULL REMARK 200 DATA REDUNDANCY IN SHELL : NULL REMARK 200 R MERGE FOR SHELL (I) : NULL REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 <I/SIGMA(I)> FOR SHELL : NULL REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: AMORE REMARK 200 STARTING MODEL: ERB+W196 COMPLEX STRUCTURE REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 40.48 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.07 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: PRECIPITANT: PEG3350, MG FORMATE, PH REMARK 280 8.0, VAPOR DIFFUSION, HANGING DROP, TEMPERATURE 291K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 21 21 21 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X+1/2,-Y,Z+1/2 REMARK 290 3555 -X,Y+1/2,-Z+1/2 REMARK 290 4555 X+1/2,-Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 26.06500 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 50.22950 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 44.33800 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 50.22950 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 26.06500 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 44.33800 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 300 REMARK: THIS A DIMER STRUCTURE. REMARK 300 THE SECOND PART OF THE BIOLOGICAL ASSEMBLY IS GENERATED REMARK 300 BY A NON-CRYSTALLOGRAPHIC TWO-FOLD AXIS. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: TETRAMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B, C, D REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 TYR A 411 REMARK 465 PRO A 412 REMARK 465 LEU A 413 REMARK 465 VAL A 414 REMARK 465 THR A 415 REMARK 465 ALA A 416 REMARK 465 THR A 417 REMARK 465 GLN A 418 REMARK 465 ASP A 419 REMARK 465 ALA A 420 REMARK 465 TYR B 411 REMARK 465 PRO B 412 REMARK 465 LEU B 413 REMARK 465 VAL B 414 REMARK 465 THR B 415 REMARK 465 ALA B 416 REMARK 465 THR B 417 REMARK 465 GLN B 418 REMARK 465 ASP B 419 REMARK 465 ALA B 420 REMARK 465 HIS B 498 REMARK 465 VAL B 499 REMARK 465 LEU B 500 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 SER A 409 OG REMARK 470 ASP A 421 CG OD1 OD2 REMARK 470 SER B 409 OG REMARK 470 ASP B 421 CG OD1 OD2 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS IN SAME ASYMMETRIC UNIT REMARK 500 REMARK 500 THE FOLLOWING ATOMS ARE IN CLOSE CONTACT. REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI DISTANCE REMARK 500 NH2 ARG A 364 O HOH A 226 2.05 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS REMARK 500 REMARK 500 THE FOLLOWING ATOMS THAT ARE RELATED BY CRYSTALLOGRAPHIC REMARK 500 SYMMETRY ARE IN CLOSE CONTACT. AN ATOM LOCATED WITHIN 0.15 REMARK 500 ANGSTROMS OF A SYMMETRY RELATED ATOM IS ASSUMED TO BE ON A REMARK 500 SPECIAL POSITION AND IS, THEREFORE, LISTED IN REMARK 375 REMARK 500 INSTEAD OF REMARK 500. ATOMS WITH NON-BLANK ALTERNATE REMARK 500 LOCATION INDICATORS ARE NOT INCLUDED IN THE CALCULATIONS. REMARK 500 REMARK 500 DISTANCE CUTOFF: REMARK 500 2.2 ANGSTROMS FOR CONTACTS NOT INVOLVING HYDROGEN ATOMS REMARK 500 1.6 ANGSTROMS FOR CONTACTS INVOLVING HYDROGEN ATOMS REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI SSYMOP DISTANCE REMARK 500 O HOH A 27 O HOH A 148 4456 2.06 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 SER A 286 131.40 -36.12 REMARK 500 ALA A 287 141.99 -171.79 REMARK 500 ASP A 363 -167.53 -125.29 REMARK 500 TYR A 488 134.04 -38.77 REMARK 500 SER B 408 37.75 -85.08 REMARK 500 SER B 409 44.18 -64.16 REMARK 500 ASP B 489 -128.82 56.62 REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE 555 A 501 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE 555 B 501 DBREF 2NV7 A 263 500 UNP Q92731 ESR2_HUMAN 263 500 DBREF 2NV7 B 263 500 UNP Q92731 ESR2_HUMAN 263 500 DBREF 2NV7 C 604 613 UNP Q15788 NCOA1_HUMAN 631 640 DBREF 2NV7 D 604 613 UNP Q15788 NCOA1_HUMAN 631 640 SEQRES 1 A 238 LEU SER PRO GLU GLN LEU VAL LEU THR LEU LEU GLU ALA SEQRES 2 A 238 GLU PRO PRO HIS VAL LEU ILE SER ARG PRO SER ALA PRO SEQRES 3 A 238 PHE THR GLU ALA SER MET MET MET SER LEU THR LYS LEU SEQRES 4 A 238 ALA ASP LYS GLU LEU VAL HIS MET ILE SER TRP ALA LYS SEQRES 5 A 238 LYS ILE PRO GLY PHE VAL GLU LEU SER LEU PHE ASP GLN SEQRES 6 A 238 VAL ARG LEU LEU GLU SER CYS TRP MET GLU VAL LEU MET SEQRES 7 A 238 MET GLY LEU MET TRP ARG SER ILE ASP HIS PRO GLY LYS SEQRES 8 A 238 LEU ILE PHE ALA PRO ASP LEU VAL LEU ASP ARG ASP GLU SEQRES 9 A 238 GLY LYS CYS VAL GLU GLY ILE LEU GLU ILE PHE ASP MET SEQRES 10 A 238 LEU LEU ALA THR THR SER ARG PHE ARG GLU LEU LYS LEU SEQRES 11 A 238 GLN HIS LYS GLU TYR LEU CYS VAL LYS ALA MET ILE LEU SEQRES 12 A 238 LEU ASN SER SER MET TYR PRO LEU VAL THR ALA THR GLN SEQRES 13 A 238 ASP ALA ASP SER SER ARG LYS LEU ALA HIS LEU LEU ASN SEQRES 14 A 238 ALA VAL THR ASP ALA LEU VAL TRP VAL ILE ALA LYS SER SEQRES 15 A 238 GLY ILE SER SER GLN GLN GLN SER MET ARG LEU ALA ASN SEQRES 16 A 238 LEU LEU MET LEU LEU SER HIS VAL ARG HIS ALA SER ASN SEQRES 17 A 238 LYS GLY MET GLU HIS LEU LEU ASN MET LYS CYS LYS ASN SEQRES 18 A 238 VAL VAL PRO VAL TYR ASP LEU LEU LEU GLU MET LEU ASN SEQRES 19 A 238 ALA HIS VAL LEU SEQRES 1 B 238 LEU SER PRO GLU GLN LEU VAL LEU THR LEU LEU GLU ALA SEQRES 2 B 238 GLU PRO PRO HIS VAL LEU ILE SER ARG PRO SER ALA PRO SEQRES 3 B 238 PHE THR GLU ALA SER MET MET MET SER LEU THR LYS LEU SEQRES 4 B 238 ALA ASP LYS GLU LEU VAL HIS MET ILE SER TRP ALA LYS SEQRES 5 B 238 LYS ILE PRO GLY PHE VAL GLU LEU SER LEU PHE ASP GLN SEQRES 6 B 238 VAL ARG LEU LEU GLU SER CYS TRP MET GLU VAL LEU MET SEQRES 7 B 238 MET GLY LEU MET TRP ARG SER ILE ASP HIS PRO GLY LYS SEQRES 8 B 238 LEU ILE PHE ALA PRO ASP LEU VAL LEU ASP ARG ASP GLU SEQRES 9 B 238 GLY LYS CYS VAL GLU GLY ILE LEU GLU ILE PHE ASP MET SEQRES 10 B 238 LEU LEU ALA THR THR SER ARG PHE ARG GLU LEU LYS LEU SEQRES 11 B 238 GLN HIS LYS GLU TYR LEU CYS VAL LYS ALA MET ILE LEU SEQRES 12 B 238 LEU ASN SER SER MET TYR PRO LEU VAL THR ALA THR GLN SEQRES 13 B 238 ASP ALA ASP SER SER ARG LYS LEU ALA HIS LEU LEU ASN SEQRES 14 B 238 ALA VAL THR ASP ALA LEU VAL TRP VAL ILE ALA LYS SER SEQRES 15 B 238 GLY ILE SER SER GLN GLN GLN SER MET ARG LEU ALA ASN SEQRES 16 B 238 LEU LEU MET LEU LEU SER HIS VAL ARG HIS ALA SER ASN SEQRES 17 B 238 LYS GLY MET GLU HIS LEU LEU ASN MET LYS CYS LYS ASN SEQRES 18 B 238 VAL VAL PRO VAL TYR ASP LEU LEU LEU GLU MET LEU ASN SEQRES 19 B 238 ALA HIS VAL LEU SEQRES 1 C 10 HIS LYS LEU VAL GLN LEU LEU THR THR THR SEQRES 1 D 10 HIS LYS LEU VAL GLN LEU LEU THR THR THR HET 555 A 501 20 HET 555 B 501 20 HETNAM 555 4-(4-HYDROXYPHENYL)-1-NAPHTHALDEHYDE OXIME FORMUL 5 555 2(C17 H13 N O2) FORMUL 7 HOH *246(H2 O) HELIX 1 1 SER A 264 GLU A 276 1 13 HELIX 2 2 THR A 290 LYS A 315 1 26 HELIX 3 3 GLY A 318 LEU A 322 5 5 HELIX 4 4 SER A 323 ILE A 348 1 26 HELIX 5 5 ASP A 363 LYS A 368 1 6 HELIX 6 6 GLY A 372 LEU A 390 1 19 HELIX 7 7 GLN A 393 ASN A 407 1 15 HELIX 8 8 SER A 422 SER A 444 1 23 HELIX 9 9 SER A 447 LYS A 482 1 36 HELIX 10 10 TYR A 488 LEU A 500 1 13 HELIX 11 11 SER B 264 GLU B 276 1 13 HELIX 12 12 THR B 290 ILE B 316 1 27 HELIX 13 13 GLY B 318 LEU B 322 5 5 HELIX 14 14 SER B 323 ILE B 348 1 26 HELIX 15 15 ASP B 365 VAL B 370 5 6 HELIX 16 16 GLY B 372 LYS B 391 1 20 HELIX 17 17 GLN B 393 ASN B 407 1 15 HELIX 18 18 ASP B 421 LYS B 443 1 23 HELIX 19 19 SER B 447 MET B 460 1 14 HELIX 20 20 LEU B 461 LYS B 482 1 22 HELIX 21 21 TYR B 488 ALA B 497 1 10 HELIX 22 22 HIS C 604 THR C 612 1 9 HELIX 23 23 HIS D 604 THR D 612 1 9 SHEET 1 A 2 LEU A 354 ALA A 357 0 SHEET 2 A 2 LEU A 360 LEU A 362 -1 O LEU A 362 N LEU A 354 SHEET 1 B 2 LYS B 353 ALA B 357 0 SHEET 2 B 2 LEU B 360 ASP B 363 -1 O LEU B 360 N ALA B 357 SITE 1 AC1 10 HOH A 68 MET A 295 LEU A 298 GLU A 305 SITE 2 AC1 10 LEU A 339 ARG A 346 ILE A 376 HIS A 475 SITE 3 AC1 10 LEU A 476 MET A 479 SITE 1 AC2 10 HOH B 11 GLU B 305 LEU B 339 ARG B 346 SITE 2 AC2 10 ILE B 373 ILE B 376 PHE B 377 HIS B 475 SITE 3 AC2 10 LEU B 476 MET B 479 CRYST1 52.130 88.676 100.459 90.00 90.00 90.00 P 21 21 21 8 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.019183 0.000000 0.000000 0.00000 SCALE2 0.000000 0.011277 0.000000 0.00000 SCALE3 0.000000 0.000000 0.009954 0.00000